Gene fusions involving ICOS-CD28 and CTLA4-CD28 have been reported in CTCL, AITL, and PTCL-NOS and infer oncogenic properties [6]. This evidence concerns the gene CD28 and mature T-cell and NK-cell non-Hodgkin lymphoma.